Blockbuster bowel cancer drug ‘could triple survival chances’ for some patients
32 patients received the immunotherapy drug before having surgery (Image: Getty) A blockbuster drug could triple survival chances for some bowel cancer patients by “melting away” their tumours, research suggests. The immunotherapy treatment, pembrolizumab, boosts the immune system’s ability to recognise and attack cancer cells. A study found that 59 percent of patients treated saw … Read more
